What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France
Marion Tano, Pascal Paubel, M. Ribault, Albane Degrassat-Théas
Topics & Concepts
BiosimilarMedicineMedical prescriptionPharmacyPaymentIncentiveFamily medicineBusinessAccountingActuarial scienceFinanceNursingInternal medicineEconomicsMicroeconomicsBiosimilars and Bioanalytical MethodsPharmaceutical Economics and PolicyNeutropenia and Cancer Infections